SentiSense Logo

SentiSense

Ctrl+K

55% OFF

Quick tip: Press

K

to search stocks

D

DGX

Quest Diagnostics Incorporated

$199.21

-4.77 (-2.34%)

Summary

Stories

News

Metrics

Fundamentals

Current Market Valuation

Current Price

$199.21

Live market price

P/E (TTM)

22.77

EPS: $8.75

P/S (TTM)

1.98

Price to Sales

TTM Quarters

4

Quarters included in TTM

Updated: 3/8/2026, 5:51:13 AM

Historical Trends

Range:

Revenue Over Time

Q1 2021Q2 2022Q3 2023Q4 2025$0B$1B$2B$2B$3B

Net Income Over Time

Q1 2021Q2 2022Q3 2023Q4 2025$0B$0B$0B$1B$1B

Short Interest (% of Float) Over Time

02/2805/3008/2902/130.0%5.0%10.0%15.0%20.0%High SI

Short Interest

4.8M

% of Float

4.4%

Days to Cover

3.3

Avg Daily Vol

1.5M

Historical income statement data up to 5 years


Historical SEC Filings

Report Period

Debt/Equity

0.79

Leverage ratio

ROE (TTM)

14.52%

Return on equity

Income Statement

Revenue

$11.04B


Cost of Revenue

$7.37B


Gross Profit

$3.67B


Operating Income

$1.56B


Net Income

$1.05B


EPS (Quarter)

$8.75


EPS (TTM)

--

Balance Sheet

Total Assets

$16.23B


Total Liabilities

$8.94B


Shareholders' Equity

$7.21B


Current Assets

$2.38B


Current Liabilities

$2.28B


Cash & Equivalents

--


Long-Term Debt

$5.67B

Cash Flow

Operating Cash Flow

$1.89B


Investing Cash Flow

$-631.00M


Financing Cash Flow

$-1.39B


Free Cash Flow

$1.25B

Profitability Margins

Gross Margin

33.21%

Operating Margin

14.10%

Net Profit Margin

9.48%


ROA (TTM)

6.45%


ROE (TTM)

14.52%

Data source: Polygon.io

Last updated: 3/8/2026, 5:51:16 AM

Company Profile

Symbol

DGX


Market Cap

$21.89B


IPO Date

Dec 17, 1996


CEO

--


Employees

56,000


Sector

--


Industry

SERVICES-MEDICAL LABORATORIES


Country

United States


Exchange

--

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Read More
SentiSense Logo

SentiSense

Sense what the market is doing.

© 2026 Compass AI Data Services, LLC. All rights reserved.


Important Disclaimer: Compass AI Data Services, LLC provides market information, sentiment analysis, and data intelligence. We do not provide investment advice, recommendations, or financial guidance. All information is for informational purposes only. Users are solely responsible for their own investment decisions. Always consult a licensed financial advisor before making investment decisions.

Cookie Preferences

We use cookies to enhance your experience and analyze site traffic. Privacy Policy